Optimi Health to Present at the ThinkEquity Conference
Optimi Health, a commercial-stage pharmaceutical company specializing in regulated psychedelic drug products for mental health therapies, announced that it will present at the ThinkEquity Conference on October 15, 2026. The presentation will cover a corporate overview and provide opportunities for one-on-one investor meetings.